✦ LIBER ✦

Epirubicin plus cyclophosphamide vs. weekly paclitaxel as primary systemic therapy in patients with stage II and III breast cancer: randomized phase II study

✍ Scribed by M. Miyashita; Kohno; S. Takao; K. Wakita; M. Konishi; H. Yoshimura; M. Kubota; Y. Kasahara; Y. Sumi; I. Kokufu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Trial of weekly pacl

✍ Giampietro Gasparini; Massimo Gion; Luigi Mariani; Paola Papaldo; Diana Crivella 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 222 KB

A randomized phase-III trial of docetaxe

✍ Keun Seok Lee; Jungsil Ro; Byung-Ho Nam; Eun Sook Lee; Youngmee Kwon; Hye Soo Kw 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 285 KB

Gemcitabine, epirubicin and docetaxel as

✍ A. Schneeweiss; J. Huober; H.-P. Sinn; D. von Fournier; C. Rudlowski; F. Belderm 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Dose-intensive adjuvant chemotherapy wit

✍ D. Elling; J. Krocker; S. Kümmel; A. Kohls; J. Heinrich; P. Breitbach; J. Blohme 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Biweekly docetaxel and gemcitabine as ne

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

147PD A PHASE II STUDY OF WEEKLY PACLITA

✍ Kim, H.T.; Yun, T.; Han, J.; Choi, H.L.; Kim, H.Y.; Lee, J.S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB